Since the central government has set a production target of 60 million doses for the country’s first mRNA Covid-19 vaccine by the end of the year, Dr Sanjay Singh, CEO of Gennova Pharmaceuticals, said production is being ramped up.

“It has been a tough journey but this is a new platform and we have to innovate to find solutions. We are trying to put our best foot forward and ramp up production,” Singh told The Indian Express on Thursday.
https://indianexpress.com/article/cities/pune/it-has-been-a-tough-j...